These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22969249)
61. Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice. Konishi H; Kikuchi S; Ochiai T; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Sonoyama T; Kokuba Y; Sasaki H; Matsui T; Otsuji E Anticancer Res; 2009 Jun; 29(6):2091-7. PubMed ID: 19528469 [TBL] [Abstract][Full Text] [Related]
62. Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. Llach F; Keshav G; Goldblat MV; Lindberg JS; Sadler R; Delmez J; Arruda J; Lau A; Slatopolsky E Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S48-54. PubMed ID: 9808143 [TBL] [Abstract][Full Text] [Related]
63. Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease. de Boer IH; Sachs M; Hoofnagle AN; Utzschneider KM; Kahn SE; Kestenbaum B; Himmelfarb J Kidney Int; 2013 Feb; 83(2):323-30. PubMed ID: 22913981 [TBL] [Abstract][Full Text] [Related]
64. Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. Dobrez DG; Mathes A; Amdahl M; Marx SE; Melnick JZ; Sprague SM Nephrol Dial Transplant; 2004 May; 19(5):1174-81. PubMed ID: 15004264 [TBL] [Abstract][Full Text] [Related]
65. A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model. Ando H; Fukushima M; Eshima K; Hasui T; Shimizu T; Ishima Y; Huang CL; Wada H; Ishida T Cancer Med; 2019 Dec; 8(17):7313-7321. PubMed ID: 31609087 [TBL] [Abstract][Full Text] [Related]
66. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. Tan X; Wen X; Liu Y J Am Soc Nephrol; 2008 Sep; 19(9):1741-52. PubMed ID: 18525004 [TBL] [Abstract][Full Text] [Related]
67. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302 [TBL] [Abstract][Full Text] [Related]
68. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
69. DN604: A platinum(II) drug candidate with classic SAR can induce apoptosis via suppressing CK2-mediated p-cdc25C subcellular localization in cancer cells. Chen F; Jin X; Zhao J; Gou S Exp Cell Res; 2018 Mar; 364(1):68-83. PubMed ID: 29397071 [TBL] [Abstract][Full Text] [Related]
70. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease. Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928 [TBL] [Abstract][Full Text] [Related]
71. Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells. Kuniyasu H; Yoshida K; Sasaki T; Sasahira T; Fujii K; Ohmori H Int J Cancer; 2006 Feb; 118(3):571-6. PubMed ID: 16106401 [TBL] [Abstract][Full Text] [Related]
72. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model. Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646 [TBL] [Abstract][Full Text] [Related]
73. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. Prudencio J; Akutsu N; Benlimame N; Wang T; Bastien Y; Lin R; Black MJ; Alaoui-Jamali MA; White JH J Natl Cancer Inst; 2001 May; 93(10):745-53. PubMed ID: 11353784 [TBL] [Abstract][Full Text] [Related]
74. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Sprague SM; Llach F; Amdahl M; Taccetta C; Batlle D Kidney Int; 2003 Apr; 63(4):1483-90. PubMed ID: 12631365 [TBL] [Abstract][Full Text] [Related]
76. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling. Wang Y; Liu Y; Tang T; Luo Y; Stevens MFG; Cheng X; Yang Y; Shi D; Zhang J; Bradshaw TD J Cell Mol Med; 2020 Jan; 24(2):1750-1759. PubMed ID: 31876059 [TBL] [Abstract][Full Text] [Related]
77. Effects of natural polysaccharides on the growth and peritoneal carcinomatosis of human gastric adenocarcinoma in a nude mouse model. Bae JS; Jang KH; Jin HK Cancer Lett; 2006 Apr; 235(1):60-8. PubMed ID: 15899545 [TBL] [Abstract][Full Text] [Related]
78. Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin. Chung S; Kim S; Kim M; Koh ES; Shin SJ; Park CW; Chang YS; Kim HS PLoS One; 2017; 12(7):e0181757. PubMed ID: 28753620 [TBL] [Abstract][Full Text] [Related]
79. Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer. Zhang C; Awasthi N; Schwarz MA; Schwarz RE J Surg Res; 2013 Jun; 182(2):227-34. PubMed ID: 23201270 [TBL] [Abstract][Full Text] [Related]
80. Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Becker LE; Koleganova N; Piecha G; Noronha IL; Zeier M; Geldyyev A; Kökeny G; Ritz E; Gross ML Am J Physiol Renal Physiol; 2011 Mar; 300(3):F772-82. PubMed ID: 21159735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]